Thursday, December 22, 2016 10:29:23 AM
Interesting chatter on the vaccine blog.
Talk that Sanofi will use an American company to augment the program that is underway with MYMX.
In addition, Sanofi to license significant American assets for use in the UK with MYMX & Sanofi to bollster their research in certain areas of vaccine research.
Dr. Fatshad Guirakkoo was recently elevated to Chief Science Officer at the American company and he is also a former Senior VP of Sanofi for Science Research.
All very interesting for MYMX, Sanofi and the American company GeoVax, symbol GOVX.
Recent YTEN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:03:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/25/2024 04:15:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:04:53 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 07/19/2024 01:20:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 12:38:28 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM